Assignee
REVIVICOR INC
US·8 granted patents·8 pending applications·55 citations·filing 2003–2024
Top patents by PatentIndex Score
16 records- 0191US7795493B2Porcine animals lacking any expression of functional alpha 1, 3 galactosyltransferaseREVIVICOR INC·Filed 2003·Granted Sep 14, 2010·34 cites·8 claims
- 0287US10149461B2Immunocompromised ungulatesREVIVICOR INC·Filed 2015·Granted Dec 11, 2018·9 cites·16 claims
- 0387US10130737B2Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferaseREVIVICOR INC·Filed 2014·Granted Nov 20, 2018·10 cites·21 claims
- 0477US11172658B2Porcine animals lacking expression of functional alpha 1, 3 galactosyltransferaseREVIVICOR INC·Filed 2018·Granted Nov 16, 2021·1 cites·4 claims
- 0571US11085054B2Ungulates with genetically modified immune systemsREVIVICOR INC·Filed 2019·Granted Aug 10, 2021·0 cites·15 claims
- 0671US10383317B2Multi-transgenic pigs for diabetes treatmentREVIVICOR INC·Filed 2016·Granted Aug 20, 2019·1 cites·31 claims
- 0769US12569592B2Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereofREVIVICOR INC·Filed 2021·Granted Mar 10, 2026·0 cites·18 claims
- 0866US2024353409A1Novel serology assay for the detection of porcine virusesREVIVICOR INC·Filed 2024·Application pending·0 cites
- 0964US2023255185A1Multitransgenic pigs comprising ten genetic modifications for xenotransplantationREVIVICOR INC·Filed 2022·Application pending·0 cites
- 1061US2017183685A1Ungulates with Genetically Modified Immune SystemsREVIVICOR INC·Filed 2017·Application pending·0 cites
- 1158US10912863B2Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferaseREVIVICOR INC·Filed 2018·Granted Feb 9, 2021·0 cites·12 claims
- 1252US2022211018A1Multi-transgenic pigs with growth hormone receptor knockout for xenotransplantationREVIVICOR INC·Filed 2021·Application pending·0 cites
- 1351US2009049562A1Porcine cmp-n-acetylneuraminic acid hydroxylase geneREVIVICOR INC·Filed 2008·Application pending·0 cites
- 1448US2022257829A1Compositions and methods for preventing allergiesREVIVICOR INC·Filed 2019·Application pending·0 cites
- 1544US2006147432A1Tolerogenic antigen-presenting cellsREVIVICOR INC·Filed 2006·Application pending·0 cites
- 1636US2018249688A1Multi-Transgenic Pig for XenotransplantationREVIVICOR INC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →